DFTX NASDAQ
Definium Therapeutics, Inc.
1W: +3.4%
1M: -3.9%
3M: -15.6%
YTD: +174.2%
$37.40
-0.20 (-0.53%)
Weekly Expected Move ±7.4%
$32
$35
$37
$40
$43
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-08-14
Earliest Filing
2024-10-17
Latest Filing
partner: 3
investor: 2
Counterparties (Filed by DFTX)
5 relationshipsCompanies named in DFTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Commodore Capital Master LP | — | investor | Investor in private placement and holder of exchange warrants | 2024-10-17 | View |
| Deep Track Biotechnology Master Fund, LTD | — | investor | Investor in private placement and holder of exchange warrants | 2024-10-17 | View |
| Leerink Partners LLC | — | partner | Representative of underwriters in the public offering | 2024-08-12 | View |
| Evercore Group L.L.C. | EVR | partner | Representative of underwriters in the public offering | 2024-08-12 | View |
| Ankura Trust Company, LLC | — | partner | Collateral Trustee for the Lenders | 2023-08-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-08 | Other Events; Exhibits | View | |
| 2026-08-12 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-24 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-06-22 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-12 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-19 | Other Events; Exhibits | View | |
| 2026-05-12 | Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-04-22 | Other Events; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-29 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Amendments to Articles of Incorporation or Bylaws; Ot | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-31 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-10-29 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-31 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-16 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-27 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR